J. Rosenstock

发表论文 524 篇 · 总被引 60158 次 · h-index 108

代表论文

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. (2023 · The Lancet · 被引 564)
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. (2023 · The Lancet · 被引 304)
Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial. (2023 · Journal of the American College of Cardiology · 被引 166)
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations. (2023 · Journal of the American College of Cardiology · 被引 125)
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. (2023 · New England Journal of Medicine · 被引 119)
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial. (2023 · The Lancet · 被引 99)